Johnson & Johnson Vaccine Increases Risk Of Rare Nerve Disorder, Warns US FDA
The US FDA on Monday issued a letter to the company and classified the chances of getting Guillain-Barré syndrome (GBS) after vaccination as being “very low.” Still, J&J vaccine recipients…
Share